Gene expression in the early stages of embryogenesis
Impact of ionomycin on the expression levels of genes related to apoptosis (Bax and Bcl-2)
Gene expression of the BAX gene was estimated in embryos from the early stages of embryogenesis. We observed lower gene expression of the BAX gene in the groups supplemented with 25 and 50 nM ionomycin compared to that in the control group. However, the difference was not significant between the groups. In the group given 50 nM ionomycin, gene expression of the BCL2 gene was significantly (P<0.05) reduced compared to that in the control and Ionomycin 25 nM groups (Fig 1).
Impact of ionomycin on the expression levels of genes related to stress (HSPB1)
The effect of ionomycin supplementation on HSPB1 gene expression in embryos from the early stages of embryogenesis was studied. Compared to the control group, there were significant differences (P<0.05) in the gene expression of the HSPB1 gene in the group supplemented with 25 nM ionomycin (Fig 1).
Impact of ionomycin on the expression levels of genes related to granulosa cell development, nuclear maturation and embryo development (GDF9)
Gene expression of the GDF9 gene was estimated in embryos starting from the early stages of embryogenesis. Compared to the control group, we observed higher gene expression of the GDF9 gene in the groups supplemented with 25 and 50 nM ionomycin, but the difference was not significant between the groups (Fig 1).
Impact of ionomycin on the expression levels of genes related to cell development and differentiation (IGF1)
Gene expression of the IGF1 gene was estimated in embryos from the early stages of embryogenesis. IGF1 expression was significantly lower (P<0.05) in the groups supplemented with 50 nM ionomycin compared to that in the control and ionomycin 25 nM groups (Fig 1).
Gene expression in the late stages of embryogenesis
Impact of ionomycin on the expression levels of genes related to apoptosis (Bax and Bcl-2)
Gene expression of the BAX gene was estimated in embryos from the late stages of embryogenesis. We observed lower gene expression of the BAX gene in groups supplemented with 25 and 50 nM ionomycin. In addition, the ratio of Bcl-2 was lower in the groups supplemented with 25 and 50 nM ionomycin (P<0.05) than that in the control group (Fig 2).
Impact of ionomycin on the expression levels of genes related to stress (HSPB1)
The gene expression of HSBP1 was determined in embryos from the late stages of embryogenesis. HSPB1 expression was significantly higher (P<0.05) in the group supplemented with 50 nM ionomycin, with a non-significant difference observed between the group supplemented with 25 nM ionomycin and the control group (Fig 2).
Impact of ionomycin on the expression levels of genes related to granulosa cell development, nuclear maturation and embryo development (GDF9)
The gene expression of GDF9 was determined in embryos from the late stages of embryogenesis. GDF9 expression was a significantly higher (P<0.05) in the group supplemented with 25 nM ionomycin, with a non-significant difference observed between the group supplemented with 50 nM ionomycin and the control group (Fig 2).
Impact of ionomycin on the expression levels of genes related to cell development and differentiation (IGF1)
The gene expression of IGF1 was determined in embryos from the late stages of embryogenesis. The group supplied 50nM ionomycin showed significantly decreased IGF1 expression (P<0.05), in comparison to the control and 25 nM ionomycin groups (Fig 2).
The aim of this study was to evaluate the expression of genes (Bcl-2, Bax, HSPB1, IGF1 and GDF9) in different stages of bovine embryos produced
in vitro by investigating the effects of applying 25 and 50 nM ionomycin to the sperm capacitation medium. This analysis was performed to elucidate the effects of treating the sperm with ionomycin before fertilization by either down regulating or upregulating of the paternal gene expiration epically in the IVEP.
For a normal developing embryo, the expression of both maternal and paternal genes is required. An intense epigenetic change occurs upon fertilization to establish pluripotency
(Mclay et al., 2003).
Several factors are involved in the regulation of parental genes in preimplantation embryos (
Tulay, 2017).
Maternal gene expression was activated in the early embryo cleavage stages (from the zygote until the 4 to 8 cell stage), while paternal gene expression began after the 4-8 cell stage. Such paternal effects may be mediated by paternally induced epigenetic modifications during early embryogenesis, as outline by
Valleh et al., (2015). The genes selected for this study (BAX, BCL-2, HSP-70, GDF-9 and IGF1) are sensitive in the IVEP and might also correspond to the aims of this study. The results showed that the treated (25 and 50 nM ionomycin) sperm groups experienced variations in the expression of the apoptotic and cell death genes BAX and the Bcl-2 between the treated and the control groups during early cleavage. BAX did not show any differences. However, during late cleavage development, the control group presented higher gene expression than that in the two treatment groups. This difference possibly emerged because the gene expression of treated BAX was down regulated in the early cleavage stage and upregulated in the late cleavage stage. The Bcl-2 gene of the control group showed higher gene expression in both the early (from zygote to the 32-cell stage) and late cleavage stages (morula to blastula cleavage stages), compared to that in the treated group. The differences in the expression of this gene disagree with the results of
Valleh et al., (2015) because this previous study used different male sperm from different breeds without any treatment of the sperm prior to fertilization. The effects of altered gene expression patterns on
in vitro produced bovine embryos, particularly when cultured under suboptimal conditions, were reflected by the occurrence of clinically important phenomena such as apoptosis, as reported in
Badr et al., (2007). This previous review focused on the morphogenetic embryo development and gene expression profile in IVP embryos, with emphasis on the different parameters that may alter gene expression patterns during the critical period of
in vitro embryo culture. However, our study provides results even during the sperm capacitation time. In addition, the Bcl-2 in the more strongly treated sperm group (50 nM) was expressed more highly than that in the 25 nM ionomycin and control groups. This result agrees with other studies that showed variation in the gene expression of
in vitro bovines during early embryo development
(Yang and Rajamahendran, 2002; Kim et al., 2004; Ebrahimi et al., 2010; Barakat et al., 2015; Al-Malahi et al., 2022). In early embryo development, the less-strongly treated sperm group (25 nM ionomycin) presented lower HSP-1 gene expression than that in the control group, while the more strongly treated sperm group (50 nM ionomycin) did not show any significant differences. These results agree with those of
Oliveira et al., (2005) who showed that Hsp70 gene expression varies between distinct stages of embryo development and embryo density levels. These differences might negatively affect the patterns of gene expression for
in vitro produced bovine embryos. This phenomenon might have negatively affected the patterns of gene expression among
in vitro produced bovine embryos (
de Oliveira et al., 2005), as well as the pH-induced changes in the structure of the heat shock protein HspB1, as indicated by
Chernik et al., (2004).
The result of GDF-9 gene expression did not show differences between the treated and control groups in the early cleavage stage, while during the late cleavage stages, we observed higher gene expression levels in the 25nM ionomycin-treated group compared to the control and the 50 nM ionomycin-treated group. These results disagree with the findings of
Tali et al., (2019), where GDF9 showed the highest expression in immature ovine oocytes, which decreased during maturation and embryo production. This difference might be attributable to the differences between ovine and bovine IVEP.
The present study showed higher levels of IGF1 gene expression in the control group compared to that in both treated groups; these levels decreased with an increase in the treatment dose. This result agrees with the
in vitro production of bovine embryos, which were found to negatively affect the amount of IGF1 gene expression on day 7 (
Bertolini, 2002). This result conflicts with the results for mouse IVEP, in which a significant association was found between IGF-1 expression and blastocyst formation
in vitro (P<0.01)
(Kowalik et al., 1999). This result may be due to the epigenetic effects of the paternal gene caused by sperm treatment before fertilization and the downregulation of gene expression in bovine IGF1.